Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation
暂无分享,去创建一个
D. Bulters | S. Bandyopadhyay | I. Galea | D. Schaer | R. Humar | M. Hugelshofer | Diederik Bulters | I. Galea | Dominik Schaer | Dominik J. Schaer
[1] V. Rohde,et al. The value of comorbidities and illness severity scores as prognostic tools for early outcome estimation in patients with aneurysmal subarachnoid hemorrhage , 2022, Neurosurgical Review.
[2] Bum-Tae Kim,et al. Elevated blood viscosity is associated with delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. , 2022, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[3] F. Vallelian,et al. Erythrophagocytes in hemolytic anemia, wound healing, and cancer. , 2022, Trends in molecular medicine.
[4] D. Bulters,et al. Long‐term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employment , 2022, European journal of neurology.
[5] P. Buehler,et al. Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics , 2022, Blood.
[6] S. Love,et al. Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage , 2022, Stroke.
[7] D. Bulters,et al. Auditory outcome following aneurysmal subarachnoid haemorrhage , 2021, Journal of the Neurological Sciences.
[8] W. Tapper,et al. Long-Term Cognitive Outcome following Aneurysmal Subarachnoid Haemorrhage. , 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[9] B. Hoh,et al. Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review , 2021, Journal of the American Heart Association.
[10] S. Blackburn,et al. Role of platelets in the pathogenesis of delayed injury after subarachnoid hemorrhage , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Joshua Henshaw,et al. Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic disease , 2021, Clinical and translational science.
[12] H. Hoe,et al. Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease , 2021, Ageing Research Reviews.
[13] E. Keller,et al. Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury , 2021, medRxiv.
[14] H. Zetterberg,et al. Neurofilament light predicts neurological outcome after subarachnoid haemorrhage , 2021, Brain : a journal of neurology.
[15] K. Hynynen,et al. Role of perivascular and meningeal macrophages in outcome following experimental subarachnoid hemorrhage , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] S. Doré,et al. Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage. , 2020, Current Neurovascular Research.
[17] P. Slasor,et al. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration , 2020, Clinical and translational science.
[18] P. Lazzerini,et al. Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage. , 2020, Heart, lung & circulation.
[19] Tom R. Gaunt,et al. Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[20] S. Moestrup,et al. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin , 2020, Brain communications.
[21] E. Keller,et al. Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm. , 2019, The Journal of clinical investigation.
[22] A. Adamides,et al. The role of haptoglobin and hemopexin in the prevention of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a review of current literature , 2019, Neurosurgical Review.
[23] Haiying Li,et al. RIP3 participates in early brain injury after experimental subarachnoid hemorrhage in rats by inducing necroptosis , 2019, Neurobiology of Disease.
[24] A. Algra,et al. Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis , 2019, JAMA neurology.
[25] S. Blackburn,et al. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage , 2019, Neurology.
[26] B. Pakkenberg,et al. Early focal brain injury after subarachnoid hemorrhage correlates with spreading depolarizations , 2018, Neurology.
[27] V. Caron,et al. United states. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[28] W. Jusko,et al. Role of Interstitial Fluid Turnover on Target Suppression by Therapeutic Biologics Using a Minimal Physiologically Based Pharmacokinetic Model , 2018, The Journal of Pharmacology and Experimental Therapeutics.
[29] S. Blackburn,et al. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications , 2018, Nature Reviews Neurology.
[30] P. Buehler,et al. Revisiting the putative role of heme as a trigger of inflammation , 2018, Pharmacology research & perspectives.
[31] P. Buehler,et al. Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics , 2018, BMC Biotechnology.
[32] M. Meyerand,et al. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery , 2017, The Journal of physiology.
[33] D. Vivien,et al. Subarachnoid Hemorrhage Severely Impairs Brain Parenchymal Cerebrospinal Fluid Circulation in Nonhuman Primate , 2017, Stroke.
[34] A. Nowacki,et al. The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage , 2017, Neurocritical Care.
[35] C. Ayata,et al. Challenges and Controversies in Translational Stroke Research - an Introduction , 2016, Translational Stroke Research.
[36] R. Regan,et al. Haptoglobin increases the vulnerability of CD163‐expressing neurons to hemoglobin , 2016, Journal of neurochemistry.
[37] R. Weissleder,et al. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver , 2016, Nature Medicine.
[38] H. Brkić,et al. Impact of Comorbidity on Early Outcome of Patients with Subarachnoid Hemorrhage Caused by Cerebral Aneurysm Rupture , 2015, Medical archives.
[39] K. Venkatakrishnan,et al. Physiologically based and population PK modeling in optimizing drug development: A predict–learn–confirm analysis , 2015, Clinical pharmacology and therapeutics.
[40] C. Ogilvy,et al. Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1. , 2015, The Journal of clinical investigation.
[41] H. Patel,et al. Impact of specialist neurovascular care in subarachnoid haemorrhage , 2015, Clinical Neurology and Neurosurgery.
[42] P. Buehler,et al. Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress , 2014, Cell Death and Differentiation.
[43] C. O’Neill,et al. Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: safety, pharmacokinetics, and distribution. , 2014, Toxicology and applied pharmacology.
[44] Tian Feng,et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. , 2013, The Journal of clinical investigation.
[45] P. Buehler,et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. , 2013, Blood.
[46] I. Galea,et al. The intrathecal CD163-haptoglobin–hemoglobin scavenging system in subarachnoid hemorrhage , 2012, Journal of neurochemistry.
[47] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[48] V. Friedrich,et al. Cell death starts early after subarachnoid hemorrhage , 2012, Neuroscience Letters.
[49] J. Dreier. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease , 2011, Nature Medicine.
[50] J. Grotta,et al. Neuroprotective Role of Haptoglobin after Intracerebral Hemorrhage , 2009, The Journal of Neuroscience.
[51] R. Zenobi,et al. Characterization of high molecular weight multimeric states of human haptoglobin and hemoglobin-based oxygen carriers by high-mass MALDI MS. , 2009, Journal of separation science.
[52] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[53] Joseph F. Clark,et al. Bilirubin Oxidation Products (BOXes) and Their Role in Cerebral Vasospasm after Subarachnoid Hemorrhage , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[54] P. Højrup,et al. Identification of the receptor scavenging hemopexin-heme complexes. , 2005, Blood.
[55] A. Lagares,et al. Global cerebral edema after subarachnoid hemorrhage. , 2002, Stroke.
[56] D. Hanley,et al. Blood Clot Resolution in Human Cerebrospinal Fluid: Evidence of First-order Kinetics , 2001, Neurosurgery.
[57] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[58] J. Bederson,et al. Acute Decrease in Cerebral Nitric Oxide Levels after Subarachnoid Hemorrhage , 2000, Journal of Cerebral Blood Flow and Metabolism.
[59] Ulrich Dirnagl,et al. Nitric Oxide Scavenging by Hemoglobin or Nitric Oxide Synthase Inhibition by N-Nitro-L-Arginine Induces Cortical Spreading Ischemia When K+ Is Increased in the Subarachnoid Space , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[60] J. Holmes,et al. Lifetime cost of stroke in the United States. , 1996, Stroke.
[61] J. Eaton,et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[62] C. Patlak,et al. Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.
[63] T. Asano,et al. Identification of 5‐Hydroxy Eicosatetraenoic Acid in Cerebrospinal Fluid After Subarachnoid Hemorrhage , 1983, Journal of neurochemistry.
[64] M. Miyaoka,et al. Etiology and Treatment of Prolonged Vasospasm , 1976 .
[65] I. J. Jackson,et al. Aseptic hemogenic meningitis; an experimental study of aseptic meningeal reactions due to blood and its breakdown products. , 1949, Archives of neurology and psychiatry.
[66] A. Gressner,et al. Haptoglobin , 2019, Springer Reference Medizin.
[67] V. Perry,et al. What is immune privilege (not)? , 2007, Trends in immunology.
[68] F. Hasson,et al. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. , 2006, Journal of advanced nursing.
[69] V. Krahn. Phagocytosis of erythrocytes in the subarachnoid space at spinal nerve exits , 2004, Cell and Tissue Research.
[70] K. Vandegriff,et al. Assessment of hemoglobin-dependent neurotoxicity: alpha-alpha crosslinked hemoglobin. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.
[71] M. Miyaoka,et al. Etiology and treatment of vasospasm following subarachnoid hemorrhage. , 1979, Neurologia medico-chirurgica.